Daehan Nupharm Co.,Ltd.

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 63.7 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

Upper percentile

Top 1.8% in sector — P/E (price-to-earnings)Price attractiveness →Top 10.3% in sector — ROE (return on equity)Financial strength →Top 12.9% in sector — Dividend yieldShareholder Return →

Lower percentile

Bottom 21.1% in sector — Operating income change (YoY)Growth momentum →Bottom 26.1% in sector — Operating income change (3Y)Growth momentum →Bottom 27.3% in sector — Debt-to-equity ratioFinancial strength →

1-year closing price

Low ₩5,090High ₩7,510

Latest close

Price change by period

1.20%

1.60%

0.00%

18.30%

As of the Sep 2, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

Financial strength

58.3/100

How much debt does it carry relative to equity?

93.8%

Sector median 51.6%

Sector low

highBottom 27.3% in sector

Can it cover what's due within a year?

155.2%

Sector median 191.7%

Sector low

highBottom 42.7% in sector

How much of revenue becomes profit?

5.8%

Sector median -2.4%

Sector low

highTop 26.4% in sector

How much did it earn on its own capital?

10.9%

Sector median -4.5%

Sector low

highTop 10.3% in sector

Source filing: annual report (separate) — view original ↗

Growth momentum

28.6/100

How much did revenue grow in a year?

0.1%

Sector median 6.4%

Sector low

highBottom 33% in sector

Has it grown steadily over three years?

0.7%

Sector median 4.9%

Sector low

highBottom 34.3% in sector

Did core profits grow in a year?

-37.2%

Sector median 3.6%

Sector low

highBottom 21.1% in sector

Are core profits higher than three years ago?

-57.5%

Sector median 3.5%

Sector low

highBottom 26.1% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (separate) — view original ↗

Price attractiveness

91.3/100

Is the price expensive relative to earnings?

5.4x

Sector median P/E of profitable peers 16.3x · 58% loss-making

Sector low

highTop 1.8% in sector

Is the price expensive relative to book value?

0.59x

Sector median 1.61x

Sector low

highTop 15.6% in sector

Valuation uses the Sep 2, 2026 close and market cap

Shareholder Return

Single-indicator axis87.1/100

Does the company actually pay dividends?

1.5%

Sector median 0.0%

Sector low

highTop 12.9% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025): ₩1.4B
Treasury shares (FY2025): 319,631 shares (2.2% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (separate) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 3 met · 6 not met · 0 not computable

Not metMetNot computable

Positive net income

Whether net income (attributable to owners where available) is above zero.

Met

₩15.3B

Positive operating cash flow

Whether cash flow from operations is above zero.

Met

₩5.1B

Return on assets up

Whether net income over beginning total assets rose from the prior year.

Not met

8.7% → 6.9%

Operating cash flow exceeds net income

Whether operating cash flow is greater than net income.

Not met

₩5.1B vs ₩15.3B

Liabilities-to-assets ratio down

Whether total liabilities as a share of total assets fell from the prior year.

Not met

43.3% → 48.4%

Current ratio up

Whether current assets over current liabilities rose from the prior year.

Not met

160.5% → 155.2%

Shares outstanding not increased

Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.

Met

14,354,920 → 14,354,920

Operating margin up

Whether operating income over revenue rose from the prior year.

Not met

9.2% → 5.8%

Asset turnover up

Whether revenue over beginning total assets rose from the prior year.

Not met

1.14x → 0.91x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (separate) — view original ↗

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Position within sector

1-year closing price

Financial strength

Growth momentum

Financial trend

Revenue

Growth & margin

Year over year — alongside the sector median

Price attractiveness

Shareholder Return

Dividend per share (annual)

Dividends & treasury shares

Financial checklist

Grade change history

Recent filings for this stock